paclitaxel has been researched along with Angina, Stable in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhalraam, U; Corballis, N; Eccleshall, SC; Gilbert, T; Gunawardena, T; Maart, C; Mamas, MA; Merinopoulos, I; Mohamed, MO; Richardson, P; Ryding, A; Sarev, T; Sawh, C; Sulfi, S; Vassiliou, VS; Wickramarachchi, U; Wistow, T | 1 |
| Garg, S; Her, AY; Kim, YH; Shin, ES | 1 |
| Chello, M; Coccia, R; Covino, E; De Marco, F; Di Domenico, F; Di Sciascio, G; Lusini, M; Patti, G; Pettinari, M; Pollari, F; Spadaccio, C; Zanzonico, R | 1 |
| Angioli, P; Bolognese, L; Ducci, K; Falsini, G; Grotti, S; Liistro, F; Porto, I | 1 |
| Bil, J; Gil, RJ; Kulawik, T; Pawlowski, T; Rzezak, J; Vassilev, D | 1 |
| Allocco, D; Dawkins, KD; Ellis, SG; Guagliumi, G; Jiang, S; Kobayashi, N; Maehara, A; McAndrew, TC; Mintz, GS; Ormiston, JA; Stone, GW; Turco, MA; Weissman, NJ; Witzenbichler, B | 1 |
| Berti, S; Ciardetti, M; Coceani, M; Palmieri, C; Pastormerlo, LE; Ravani, M; Rizza, A; Shlueter, M; Trianni, G; Vaghetti, M | 1 |
| Chibana, H; Fukumoto, Y; Ikeno, F; Itaya, N; Mitsutake, Y; Nakayoshi, T; Sasaki, K; Sasaki, M; Ueno, T; Yokoyama, S | 1 |
| Amano, T; Ando, H; Hayakawa, S; Hayashi, M; Ishii, H; Kumagai, S; Matsudaira, K; Matsumoto, M; Murohara, T; Okada, T; Tanaka, M; Yoshikawa, D | 1 |
| Buszman, PE; Buszman, PP; Drzewiecki, J; Granada, JF; Kaluza, GL; Kozlowski, M; Milewski, K; Orlik, B; Peppas, A; Pruski, M; Trela, B | 1 |
1 trial(s) available for paclitaxel and Angina, Stable
| Article | Year |
|---|---|
Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Topics: Aged; Aged, 80 and over; Angina, Stable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome | 2013 |
9 other study(ies) available for paclitaxel and Angina, Stable
| Article | Year |
|---|---|
Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice.
Topics: Angina, Stable; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Treatment Outcome | 2023 |
Impact of paclitaxel-coated balloon versus newer-generation drug-eluting stent on periprocedural myocardial infarction in stable angina patients.
Topics: Aged; Angina, Stable; Angioplasty, Balloon, Coronary; Biomarkers; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Creatine Kinase, MB Form; Databases, Factual; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Propensity Score; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Troponin T | 2018 |
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
Topics: Aged; Angina, Stable; Atorvastatin; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Diabetes Complications; Drug-Eluting Stents; Female; Glycation End Products, Advanced; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Pyrroles; ROC Curve; Tubulin Modulators | 2013 |
Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis.
Topics: Aged; Angina, Stable; Angioplasty; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Treatment Outcome | 2014 |
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies.
Topics: Aged; Angina, Stable; Angina, Unstable; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Tubulin Modulators; Ultrasonography, Interventional | 2014 |
Drug eluting balloon: a multipurpose tool for coronary revascularization with optimal long-term follow-up results.
Topics: Adult; Aged; Aged, 80 and over; Angina, Stable; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Registries | 2014 |
Serial changes of coronary endothelial function and arterial healing after paclitaxel-eluting stent implantation.
Topics: Acetylcholine; Aged; Angina, Stable; Angioscopy; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitroglycerin; Paclitaxel; Percutaneous Coronary Intervention; Tunica Intima; Vasodilator Agents | 2016 |
Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris.
Topics: Aged; Angina, Stable; Biomarkers; Creatine Kinase, MB Form; Drug-Eluting Stents; Female; Heart Injuries; Humans; Logistic Models; Male; Metals; Paclitaxel; Sirolimus; Stents | 2012 |
Comparable clinical safety and efficacy of biodegradable versus durable polymer paclitaxel eluting stents despite shorter dual antiplatelet therapy: insights from a multicenter, propensity score-matched registry.
Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Angina, Stable; Cardiovascular Agents; Coronary Stenosis; Coronary Thrombosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Poland; Polymers; Propensity Score; Prosthesis Design; Registries; Retrospective Studies; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2013 |